CLINICAL_TRIALS
research
· 2025-04-18
Clinical Trial Update: Neoadjuvant QL1706 Therapy for ESCC [Phase 2]
Summary
A Phase 2 neoadjuvant trial evaluating QL1706 for locally advanced resectable esophageal squamous cell carcinoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shandong Provincial Hospital | Conditions: Locally Advanced Resectable Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING